AMSilk GmbH
Biotechnology, Medical Technology, Nanotechnology, New Materials
-
Short facts
-
- Research & Development
- Year founded 2008
- 25 Employees (site)
- Turnover: not available
Products/services: The AMSilk®-Technology enables the production of biopolymers such as spider silk on an industrial scale. These materials are unrivaled by most common synthetic materials. AMSilk addresses many applications and industry sectors with new materials enabling new products with previously unachievable features. Tailor-made materials using the AMSilk®-Technology enable new and superior products with previously unachievable features, spanning multiple industries and applications
Basic data
Company
AMSilk GmbH
Street
Am Klopferspitz 19
PC / City
82152 Planegg
County
Upper Bavaria
Phone
+49 89 5795393-0
Fax
not available
Homepage
Language skills
English, German
Contact person
Management, Research & development: Dr. Lin Römer (Mr.)
Profile/competences
Core competencies
AMSilk is the world's first industrial supplier of synthetic silk biopolymers produced by a patented biotechnological process
Key sectors / sub-sectors
- Biotechnology: Biomaterials
- Biotechnology: Drug delivery
- Biotechnology: Tissue engineering and regenerative medicine
- Medical Technology: Implants, biomaterials, tissue engineering
- Nanotechnology: Biocompatible materials and layers
- Nanotechnology: Drug encapsulation, targeted drug delivery
- New Materials: Fibers and textiles
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available